Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,612,300
+$2,806,068 QoQ
Shares Held
2,439,450
+20.5% QoQ
Ownership
0.988%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. ARDX ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in ARDX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,612,300 | 2,439,450 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $11,806,232 | 2,025,083 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $11,814,121 | 2,144,124 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,064,461 | 2,312,363 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $7,723,736 | 1,573,063 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,764,411 | 545,249 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,262,007 | 618,579 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,085,175 | 416,353 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,237,598 | 169,534 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $547,571 | 88,318 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $252,580 | 61,907 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $231,781 | 68,372 | Shares | Defined | 2023-08-14 | |
| 2022-06-30 | $11,873 | 20,125 | Shares | Defined | 2022-08-15 | |
| 2020-12-31 | $280,034 | 43,282 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $899,708 | 171,373 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,706,645 | 246,625 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $1,374,195 | 241,723 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||